Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

COTI selected for Canadian life sciences partnering mission

Critical Outcome Technologies Inc. announced today that the Company was selected by the Consulate General of Canada and BIOTECanada to attend a life sciences partnering mission in Boston, MA. This initiative is being held in conjunction with the BioPharm America conference taking place September 15-17, 2010.

15 Sep 2010

Study on spinal cord stem cells paves way for post stroke symptom treatment

Neuralstem, Inc. announced that its spinal cord stem cells survived in rat brains affected by stroke and differentiated predominantly into neurons. The transplanted animals showed significant improvement in some motor skill and strength measurements. The study entitled, "Intracerebral Implantation of Adherent Human Neural Stem Cells To Reverse Motor Deficits in Chronic Stroke Rats," was presented earlier today by senior study author, Dr. Shinn-Zong Lin, M.D., Ph.D., at the Stem Cells USA & Regenerative Medicine Conference

15 Sep 2010

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

Stemedica Cell Technologies, Inc., a world leader in adult stem cell manufacturing and research, announced today that it has completed its proprietary master bank of mesenchymal bone marrow-derived stem cells.

14 Sep 2010

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.

14 Sep 2010

Metabolon receives patent for metabolic age analysis

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,781,160 entitled "Biomarkers Related to Metabolic Age and Methods Using the Same". The USPTO awarded the patent to Metabolon on August 24, 2010. This is the 12th patent issued to Metabolon.

14 Sep 2010

Study shows Americans with muscular dystrophy live longer than African-Americans

A new study shows that white men and boys are living longer with muscular dystrophy due to technological advances in recent years, but that the lives of African-American men and boys with muscular dystrophy have not been extended at the same rate. The research will be published in the September 14, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

14 Sep 2010

Structural component inside neurons dances when connections are strengthened

Scientists at Emory University School of Medicine have uncovered how a structural component inside neurons performs two coordinated dance moves when the connections between neurons are strengthened.

14 Sep 2010

Researchers to discuss brain's secrets at neuroscience conference

Top brain researchers from around the world will be in Milwaukee, Sept, 16-19, 2010, for a neuroscience conference focused on gaining insights into the brain's inner workings to better understand how the brain thinks, how the brain develops, and how the brain is altered by neurological diseases and how it responds to treatment.

14 Sep 2010

Researchers identify novel molecular pathway of Parkinson’s disease

A new study led by researchers at Columbia University Medical Center has identified a novel molecular pathway underlying Parkinson's disease and points to existing drugs which may be able to slow progression of the disease.

14 Sep 2010

Repetitive transcranial magnetic stimulation helps to regain motor function in partially paralyzed patients

Stroke patients who were left partially paralysed found that their condition improved after they received a simple and non-invasive method of brain stimulation, according to research in the September issue of the European Journal of Neurology.

14 Sep 2010

New book relates mercury in vaccines to autism

The U.S. government revealed last week that they will compensate a family millions of dollars for their daughter's injury related to her infant vaccines that contained mercury and the subsequent development of autism. Yet, the CDC continues to tell the public that there is no connection between vaccines and autism and that the mercury has been removed, although the flu shot recommended for all pregnant women, infants, and children continues to be preserved with mercury.

13 Sep 2010

Cell quality control mechanism research paves way for new understanding of neurodegenerative diseases

Scientists from The Scripps Research Institute have solved a long-standing mystery of how cells conduct "quality control" to eliminate the toxic effects of a certain kind of error in protein production. The findings may lead to a better understanding of a host of neurodegenerative diseases.

13 Sep 2010

Researchers find amyloid precursor protein function in Alzheimer's disease

In people with Alzheimer's, the brain becomes riddled with clumps of protein, forming what are known as amyloid plaques. Now, a report appearing in the September 17th print issue of Cell appears to have found a function for the amyloid precursor protein that yields the prime ingredient in those plaques.

13 Sep 2010

Researchers develop GAL4/UAS system to study human neurological diseases

A team of University of Oklahoma researchers studying neurobiology in fruit flies (Drosophila) has developed a new method for understanding brain function with potential applications in studies of human neurological diseases.

13 Sep 2010

Resverlogix announces key changes to Phase 2 ASSURE trial

Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.

10 Sep 2010

Highlights of 23rd Congress of European College of Neuropsychopharmacology 2010

More than 7,000 psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world met at the 23rd Congress of the European College of Neuropsychopharmacology (ECNP) from 28 August to 1 September 2010 in Amsterdam.

10 Sep 2010

Researchers discover generation of pyramidal neurons by glial cell precursors

In an unanticipated finding, researchers at the UC Davis School of Medicine have discovered that, during early adulthood, the brain produces new excitatory neurons, and that these neurons arise from non-neuronal support cells in an area of the brain that processes smell.

10 Sep 2010

Today's OpEds: Medicare's long-term liabilities; Reforming and funding native health care; Frustrations surrounding stem cell research

Under ObamaCare it will get much worse. Hospitals also will shut down or stop serving Medicare patients. … Everyone should know by now that Medicare suffers dramatic long-term deficits and unfunded liabilities, and is in need of fundamental, structural reforms. But effectively refusing to pay the doctors and hospitals that provide the medical care the program promises to seniors is no way to solve that problem (Peter Ferrara and Larry Hunter, 9/9).

10 Sep 2010

Researches discover reducing tau protein level can prevent Αβ protein transport in Alzheimer’s disease

Amyloid beta (Αβ) proteins, widely thought to cause Alzheimer's disease (AD), block the transport of vital cargoes inside brain cells. Scientists at the Gladstone Institute of Neurological Disease (GIND) have discovered that reducing the level of another protein, tau, can prevent Aβ from causing such traffic jams.

10 Sep 2010

Noscira receives FDA approval for Tideglusib drug to treat PSP

Noscira, a Grupo Zeltia subsidiary specialized in research and development of drugs to treat neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive Supranuclear Palsy (PSP), a fast-advancing fatal degenerative brain disorder.

10 Sep 2010

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

COTI selected for Canadian life sciences partnering mission

Study on spinal cord stem cells paves way for post stroke symptom treatment

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

Metabolon receives patent for metabolic age analysis

Study shows Americans with muscular dystrophy live longer than African-Americans

Structural component inside neurons dances when connections are strengthened

Researchers to discuss brain's secrets at neuroscience conference

Researchers identify novel molecular pathway of Parkinson’s disease

Repetitive transcranial magnetic stimulation helps to regain motor function in partially paralyzed patients

New book relates mercury in vaccines to autism

Cell quality control mechanism research paves way for new understanding of neurodegenerative diseases

Researchers find amyloid precursor protein function in Alzheimer's disease

Researchers develop GAL4/UAS system to study human neurological diseases

Resverlogix announces key changes to Phase 2 ASSURE trial

Highlights of 23rd Congress of European College of Neuropsychopharmacology 2010

Researchers discover generation of pyramidal neurons by glial cell precursors

Today's OpEds: Medicare's long-term liabilities; Reforming and funding native health care; Frustrations surrounding stem cell research

Researches discover reducing tau protein level can prevent Αβ protein transport in Alzheimer’s disease

Noscira receives FDA approval for Tideglusib drug to treat PSP

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in